MARKET

OFIX

OFIX

Orthofix Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

42.31
-1.85
-4.19%
After Hours: 42.31 0 0.00% 16:00 05/10 EDT
OPEN
44.37
PREV CLOSE
44.16
HIGH
44.98
LOW
41.81
VOLUME
146.07K
TURNOVER
--
52 WEEK HIGH
48.50
52 WEEK LOW
28.03
MARKET CAP
827.53M
P/E (TTM)
-28.2142
1D
5D
1M
3M
1Y
5Y
MedTech Round Up: Update On Products By Conformis, Medtronic, Orthofix, Neovasc
The FDA has given 510(k) clearance for Conformis Inc's (NASDAQ: 
Benzinga · 8h ago
FDA clears Orthofix's Orthonext digital platform for pediatric orthopedic procedures
Orthofix Medical (OFIX) announces expansion of its pediatric offerings with the FDA 510(k) clearance of the OrthoNext digital platform, the software tool for deformity analysis and preoperative planning for pediatric orthopedic
Seekingalpha · 12h ago
BRIEF-Orthofix Announces FDA Clearance Of The Orthonext Digital Platform
reuters.com · 13h ago
Global Orthobiologics Market Size - 2021, Emerging Development Trends, Share, Major Leading Players with Impact of Covid-19 Analysis, Industry Supply Chain, Revenue Estimates and Forecast to 2027
May 10, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The Global “Orthobiologics Market”...
The Express Wire · 14h ago
Orthofix Announces FDA Clearance of the OrthoNext Digital Platform for the JuniOrtho Plating System
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced expansion of its pediatric offerings with the U.S. Food and Drug Administration (FDA) 510(k) clearance of the OrthoNext(TM) digital pla...
BusinessWire · 14h ago
Orthofix Secures FDA Clearance for OrthoNext Digital Platform
MT Newswires · 16h ago
Interbody Cages Market by Latest Trend, Growing Demand and Technology Advancement 2026
May 07, 2021 (Market Insight Reports) -- Selbyville, Delaware, Interbody Cages market report offer in-depth analysis and comprehensive in-sights about the...
Market Insight Reports · 3d ago
Spinal Implants Market Trends, Business Overview, Key Value, Demand and Forecast 2026
May 07, 2021 (Market Insight Reports) -- Selbyville, Delaware, Spinal Implants market report offer in-depth analysis and comprehensive in-sights about the...
Market Insight Reports · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OFIX. Analyze the recent business situations of Orthofix Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OFIX stock price target is 54.00 with a high estimate of 58.00 and a low estimate of 51.00.
EPS
Institutional Holdings
Institutions: 220
Institutional Holdings: 20.63M
% Owned: 105.47%
Shares Outstanding: 19.56M
TypeInstitutionsShares
Increased
39
886.46K
New
17
483.28K
Decreased
64
1.20M
Sold Out
10
66.70K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.41%
Healthcare Equipment & Supplies
-1.41%
Key Executives
Chairman/Director/Independent Director
Ronald Matricaria
President/Chief Executive Officer/Director
Jon Serbousek
Chief Financial Officer
Doug Rice
Chief Financial Officer
Rice Doug
Chief Financial Officer
Douglas Rice
Corporate Executive
Paul Gonsalves
Corporate Executive
Kevin Kenny
Chief Administrative Officer
Kimberley Elting
Independent Director
Jason Hannon
Independent Director
James Hinrichs
Independent Director
Alexis Lukianov
Independent Director
Lilly Marks
Independent Director
Michael Paolucci
Independent Director
Maria Sainz
Independent Director
John Sicard
No Data
About OFIX
Orthofix Medical Inc., formerly Orthofix International N.V., is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Webull offers kinds of Orthofix Medical Inc stock information, including NASDAQ:OFIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OFIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OFIX stock methods without spending real money on the virtual paper trading platform.